1
|
Sasatani M, Xi Y, Daino K, Ishikawa A, Masuda Y, Kajimura J, Piao J, Zaharieva EK, Honda H, Zhou G, Hamasaki K, Kusunoki Y, Shimura T, Kakinuma S, Shimada Y, Doi K, Ishikawa‐Fujiwara T, Sotomaru Y, Kamiya K. Rev1 overexpression accelerates N-methyl-N-nitrosourea (MNU)-induced thymic lymphoma by increasing mutagenesis. Cancer Sci 2024; 115:1808-1819. [PMID: 38572512 PMCID: PMC11145157 DOI: 10.1111/cas.16159] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2023] [Revised: 02/28/2024] [Accepted: 03/10/2024] [Indexed: 04/05/2024] Open
Abstract
Rev1 has two important functions in the translesion synthesis pathway, including dCMP transferase activity, and acts as a scaffolding protein for other polymerases involved in translesion synthesis. However, the role of Rev1 in mutagenesis and tumorigenesis in vivo remains unclear. We previously generated Rev1-overexpressing (Rev1-Tg) mice and reported that they exhibited a significantly increased incidence of intestinal adenoma and thymic lymphoma (TL) after N-methyl-N-nitrosourea (MNU) treatment. In this study, we investigated mutagenesis of MNU-induced TL tumorigenesis in wild-type (WT) and Rev1-Tg mice using diverse approaches, including whole-exome sequencing (WES). In Rev1-Tg TLs, the mutation frequency was higher than that in WT TL in most cases. However, no difference in the number of nonsynonymous mutations in the Catalogue of Somatic Mutations in Cancer (COSMIC) genes was observed, and mutations involved in Notch1 and MAPK signaling were similarly detected in both TLs. Mutational signature analysis of WT and Rev1-Tg TLs revealed cosine similarity with COSMIC mutational SBS5 (aging-related) and SBS11 (alkylation-related). Interestingly, the total number of mutations, but not the genotypes of WT and Rev1-Tg, was positively correlated with the relative contribution of SBS5 in individual TLs, suggesting that genetic instability could be accelerated in Rev1-Tg TLs. Finally, we demonstrated that preleukemic cells could be detected earlier in Rev1-Tg mice than in WT mice, following MNU treatment. In conclusion, Rev1 overexpression accelerates mutagenesis and increases the incidence of MNU-induced TL by shortening the latency period, which may be associated with more frequent DNA damage-induced genetic instability.
Collapse
Grants
- Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science at Hiroshima University, Nagasaki University, and Fukushima Medical University
- NIFS10KOBS015 National Institute for Fusion Science Collaborative Research Program
- NIFS13KOBA028 National Institute for Fusion Science Collaborative Research Program
- NIFS20KOCA004 National Institute for Fusion Science Collaborative Research Program
- Initiative for Realizing Diversity in the Research Environment (Specific Correspondence Type), a support project for the Development of Human Resources in Science and Technology conducted by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- 20710043 Japan Society for the Promotion of Science, JSPS KAKENHI
- 22310037 Japan Society for the Promotion of Science, JSPS KAKENHI
- 22710055 Japan Society for the Promotion of Science, JSPS KAKENHI
- JPMX08S08080294 Nuclear Energy S&T and Human Resource Development Project
- Initiative for Realizing Diversity in the Research Environment (Specific Correspondence Type), a support project for the Development of Human Resources in Science and Technology conducted by the Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- Japan Society for the Promotion of Science, JSPS KAKENHI
Collapse
Affiliation(s)
- Megumi Sasatani
- Department of Experimental OncologyResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
| | - Yang Xi
- Department of Experimental OncologyResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
- Department of Biochemistry and Molecular Biology and Zhejiang Key Laboratory of Pathophysiology, School of Basic Medical Sciences, Health Science CenterNingbo UniversityNingboChina
| | - Kazuhiro Daino
- Department of Radiation Effects ResearchInstitute for Radiological Sciences, National Institutes for Quantum Science and TechnologyChibaJapan
| | - Atsuko Ishikawa
- Department of Radiation Effects ResearchInstitute for Radiological Sciences, National Institutes for Quantum Science and TechnologyChibaJapan
| | - Yuji Masuda
- Department of Experimental OncologyResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
- Department of Genome DynamicsResearch Institute of Environmental Medicine, Nagoya UniversityNagoyaJapan
- Department of Molecular Pharmaco‐BiologyNagoya University Graduate School of MedicineNagoyaJapan
| | - Junko Kajimura
- Department of Experimental OncologyResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
- Biosample Research Center, Radiation Effects Research FoundationHiroshimaJapan
| | - Jinlian Piao
- Department of Experimental OncologyResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
- Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health SciencesHiroshima UniversityHiroshimaJapan
| | - Elena Karamfilova Zaharieva
- Department of Experimental OncologyResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
| | - Hiroaki Honda
- Institute of Laboratory Animals, Tokyo Women's Medical UniversityTokyoJapan
| | - Guanyu Zhou
- Department of Experimental OncologyResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
| | - Kanya Hamasaki
- Department of Molecular BiosciencesRadiation Effects Research FoundationHiroshimaJapan
| | - Yoichiro Kusunoki
- Department of Molecular BiosciencesRadiation Effects Research FoundationHiroshimaJapan
| | - Tsutomu Shimura
- Department of Environmental HealthNational Institute of Public HealthSaitamaJapan
| | - Shizuko Kakinuma
- Department of Radiation Effects ResearchInstitute for Radiological Sciences, National Institutes for Quantum Science and TechnologyChibaJapan
| | | | - Kazutaka Doi
- Department of Radiation Regulatory Science ResearchInstitute for Radiological Sciences, National Institutes for Quantum Science and TechnologyChibaJapan
| | | | - Yusuke Sotomaru
- Natural Science Center for Basic Research and DevelopmentHiroshima UniversityHiroshimaJapan
| | - Kenji Kamiya
- Department of Experimental OncologyResearch Institute for Radiation Biology and Medicine, Hiroshima UniversityHiroshimaJapan
| |
Collapse
|
2
|
Stolyarenko AD, Novikova AA, Shilkin ES, Poltorachenko VA, Makarova AV. The Catalytic Activity of Human REV1 on Undamaged and Damaged DNA. Int J Mol Sci 2024; 25:4107. [PMID: 38612916 PMCID: PMC11012841 DOI: 10.3390/ijms25074107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Revised: 04/01/2024] [Accepted: 04/02/2024] [Indexed: 04/14/2024] Open
Abstract
Eukaryotic REV1 serves as a scaffold protein for the coordination of DNA polymerases during DNA translesion synthesis. Besides this structural role, REV1 is a Y-family DNA polymerase with its own distributive deoxycytidyl transferase activity. However, data about the accuracy and efficiency of DNA synthesis by REV1 in the literature are contrasting. Here, we expressed and purified the full-length human REV1 from Saccharomyces cerevisiae and characterized its activity on undamaged DNA and a wide range of damaged DNA templates. We demonstrated that REV1 carried out accurate synthesis opposite 8-oxoG and O6-meG with moderate efficiency. It also replicated thymine glycol surprisingly well in an error-prone manner, but was blocked by the intrastrand 1,2-GG cisplatin crosslink. By using the 1,N6-ethenoadenine and 7-deaza-adenine lesions, we have provided biochemical evidence of the importance for REV1 functioning of the Hoogsteen face of template A, the second preferable template after G.
Collapse
Affiliation(s)
- Anastasia D. Stolyarenko
- National Research Center “Kurchatov Institute”, 123182 Moscow, Russia; (A.A.N.); (E.S.S.); (V.A.P.)
- Institute of Gene Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
| | - Anna A. Novikova
- National Research Center “Kurchatov Institute”, 123182 Moscow, Russia; (A.A.N.); (E.S.S.); (V.A.P.)
- Institute of Gene Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
| | - Evgeniy S. Shilkin
- National Research Center “Kurchatov Institute”, 123182 Moscow, Russia; (A.A.N.); (E.S.S.); (V.A.P.)
- Institute of Gene Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
| | | | - Alena V. Makarova
- National Research Center “Kurchatov Institute”, 123182 Moscow, Russia; (A.A.N.); (E.S.S.); (V.A.P.)
- Institute of Gene Biology of the Russian Academy of Sciences, 119334 Moscow, Russia
| |
Collapse
|
3
|
Sasatani M, Zaharieva EK, Kamiya K. The in vivo role of Rev1 in mutagenesis and carcinogenesis. Genes Environ 2020; 42:9. [PMID: 32161626 PMCID: PMC7048032 DOI: 10.1186/s41021-020-0148-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2019] [Accepted: 02/05/2020] [Indexed: 11/23/2022] Open
Abstract
Translesion synthesis (TLS) is an error-prone pathway required to overcome replication blockage by DNA damage. Aberrant activation of TLS has been suggested to play a role in tumorigenesis by promoting genetic mutations. However, the precise molecular mechanisms underlying TLS-mediated tumorigenesis in vivo remain unclear. Rev1 is a member of the Y family polymerases and plays a key role in the TLS pathway. Here we introduce the existing to date Rev1-mutated mouse models, including the Rev1 transgenic (Tg) mouse model generated in our laboratory. We give an overview of the current knowledge on how different disruptions in Rev1 functions impact mutagenesis and the suggested molecular mechanisms underlying these effects. We summarize the available data from ours and others’ in vivo studies on the role of Rev1 in the initiation and promotion of cancer, emphasizing how Rev1-mutated mouse models can be used as complementary tools for future research.
Collapse
Affiliation(s)
- Megumi Sasatani
- Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553 Japan
| | - Elena Karamfilova Zaharieva
- Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553 Japan
| | - Kenji Kamiya
- Department of Experimental Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, 734-8553 Japan
| |
Collapse
|
4
|
Fujikawa Y, Ishikawa-Fujiwara T, Kuo T, Shinkai N, Shoji T, Kawasaki T, Kamei Y, Sakuraba Y, Sato A, Kinoshita M, Gondo Y, Yuba S, Tsujimura T, Sese J, Todo T. Involvement of Rev1 in alkylating agent-induced loss of heterozygosity in Oryzias latipes. Genes Cells 2020; 25:124-138. [PMID: 31917895 PMCID: PMC7079036 DOI: 10.1111/gtc.12746] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2019] [Revised: 12/25/2019] [Accepted: 12/26/2019] [Indexed: 12/21/2022]
Abstract
Translesion synthesis (TLS) polymerases mediate DNA damage bypass during replication. The TLS polymerase Rev1 has two important functions in the TLS pathway, including dCMP transferase activity and acting as a scaffolding protein for other TLS polymerases at the C‐terminus. Because of the former activity, Rev1 bypasses apurinic/apyrimidinic sites by incorporating dCMP, whereas the latter activity mediates assembly of multipolymerase complexes at the DNA lesions. We generated rev1 mutants lacking each of these two activities in Oryzias latipes (medaka) fish and analyzed cytotoxicity and mutagenicity in response to the alkylating agent diethylnitrosamine (DENA). Mutant lacking the C‐terminus was highly sensitive to DENA cytotoxicity, whereas mutant with reduced dCMP transferase activity was slightly sensitive to DENA cytotoxicity, but exhibited a higher tumorigenic rate than wild‐type fish. There was no significant difference in the frequency of DENA‐induced mutations between mutant with reduced dCMP transferase activity and wild‐type cultured cell. However, loss of heterozygosity (LOH) occurred frequently in cells with reduced dCMP transferase activity. LOH is a common genetic event in many cancer types and plays an important role on carcinogenesis. To our knowledge, this is the first report to identify the involvement of the catalytic activity of Rev1 in suppression of LOH.
Collapse
Affiliation(s)
- Yoshihiro Fujikawa
- Radioisotope Research Center, Institute for Radiation Research, Osaka University, Suita, Japan.,Radiation Biology and Medical Genetics, Department of Genome Biology, Graduate School of Medicine, Osaka University, Suita, Japan.,Japan Society for the Promotion of Science Research Fellow, Tokyo, Japan
| | - Tomoko Ishikawa-Fujiwara
- Radioisotope Research Center, Institute for Radiation Research, Osaka University, Suita, Japan.,Radiation Biology and Medical Genetics, Department of Genome Biology, Graduate School of Medicine, Osaka University, Suita, Japan
| | | | - Norio Shinkai
- Artificial Intelligence Research Center (AIRC), AIST, Tokyo, Japan.,Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, Japan.,Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan
| | - Tatsuma Shoji
- Artificial Intelligence Research Center (AIRC), AIST, Tokyo, Japan.,Humanome Lab., Inc., Tokyo, Japan
| | - Takashi Kawasaki
- Functional Biomolecular Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ikeda, Japan
| | - Yasuhiro Kamei
- Spectrography and Bioimaging Facility, National Institute for Basic Biology, Okazaki, Japan
| | - Yoshiyuki Sakuraba
- Genomic Sciences Center (GSC), RIKEN Yokohama Institute, Yokohama, Japan
| | - Ayuko Sato
- Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan
| | - Masato Kinoshita
- Division of Applied Bioscience, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
| | - Yoichi Gondo
- Genomic Sciences Center (GSC), RIKEN Yokohama Institute, Yokohama, Japan
| | - Shunsuke Yuba
- Functional Biomolecular Research Group, Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ikeda, Japan
| | - Tohru Tsujimura
- Department of Pathology, Hyogo College of Medicine, Nishinomiya, Japan
| | - Jun Sese
- RWBC-OIL, AIST, Tokyo, Japan.,Artificial Intelligence Research Center (AIRC), AIST, Tokyo, Japan.,Humanome Lab., Inc., Tokyo, Japan
| | - Takeshi Todo
- Radioisotope Research Center, Institute for Radiation Research, Osaka University, Suita, Japan.,Radiation Biology and Medical Genetics, Department of Genome Biology, Graduate School of Medicine, Osaka University, Suita, Japan
| |
Collapse
|
5
|
Suzuki M, Kino K, Kawada T, Morikawa M, Kobayashi T, Miyazawa H. Analysis of nucleotide insertion opposite 2,2,4-triamino-5(2H)-oxazolone by eukaryotic B- and Y-family DNA polymerases. Chem Res Toxicol 2015; 28:1307-16. [PMID: 26010525 DOI: 10.1021/acs.chemrestox.5b00114] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Mutations induced by oxidative DNA damage can cause diseases such as cancer. In particular, G:C-T:A and G:C-C:G transversions are caused by oxidized guanine and have been observed in the p53 and K-ras genes. We focused on an oxidized form of guanine, 2,2,4-triamino-5(2H)-oxazolone (Oz), as a cause of G:C-C:G transversions based on our earlier elucidation that DNA polymerases (Pols) α, β, γ, ε, η, I, and IV incorporate dGTP opposite Oz. The nucleotide insertion and extension of Pols δ, ζ, ι, κ, and REV1, belonging to the B- and Y-families of DNA polymerases, were analyzed for the first time. Pol δ incorporated dGTP, in common with other replicative DNA polymerases. Pol ζ incorporated dGTP and dATP, and the efficiency of elongation up to full-length beyond Oz was almost the same as that beyond G. Although nucleotide incorporation by Pols ι or κ was also error-prone, they did not extend the primer. On the other hand, the polymerase REV1 predominantly incorporated dCTP opposite Oz more efficiently than opposite 8-oxo-7,8-dihydroguanine, guanidinohydantoin, or tetrahydrofuran. Here, we demonstrate that Pol ζ can efficiently replicate DNA containing Oz and that REV1 can prevent G:C-C:G transversions caused by Oz.
Collapse
Affiliation(s)
- Masayo Suzuki
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1, Shido, Sanuki, Kagawa 769-2193, Japan
| | - Katsuhito Kino
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1, Shido, Sanuki, Kagawa 769-2193, Japan
| | - Taishu Kawada
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1, Shido, Sanuki, Kagawa 769-2193, Japan
| | - Masayuki Morikawa
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1, Shido, Sanuki, Kagawa 769-2193, Japan
| | - Takanobu Kobayashi
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1, Shido, Sanuki, Kagawa 769-2193, Japan
| | - Hiroshi Miyazawa
- Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1, Shido, Sanuki, Kagawa 769-2193, Japan
| |
Collapse
|
6
|
The DNA polymerase activity of Saccharomyces cerevisiae Rev1 is biologically significant. Genetics 2010; 187:21-35. [PMID: 20980236 DOI: 10.1534/genetics.110.124172] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023] Open
Abstract
A cell's ability to tolerate DNA damage is directly connected to the human development of diseases and cancer. To better understand the processes underlying mutagenesis, we studied the cell's reliance on the potentially error-prone translesion synthesis (TLS), and an error-free, template-switching pathway in Saccharomyces cerevisiae. The primary proteins mediating S. cerevisiae TLS are three DNA polymerases (Pols): Rev1, Pol ζ (Rev3/7), and Pol η (Rad30), all with human homologs. Rev1's noncatalytic role in recruiting other DNA polymerases is known to be important for TLS. However, the biological significance of Rev1's unusual conserved DNA polymerase activity, which inserts dC, is much less well understood. Here, we demonstrate that inactivating Rev1's DNA polymerase function sensitizes cells to both chronic and acute exposure to 4-nitroquinoline-1-oxide (4-NQO) but not to UV or cisplatin. Full Rev1-dependent resistance to 4-NQO, however, also requires the additional Rev1 functions. When error-free tolerance is disrupted through deletion of MMS2, Rev1's catalytic activity is more vital for 4-NQO resistance, possibly explaining why the biological significance of Rev1's catalytic activity has been elusive. In the presence or absence of Mms2-dependent error-free tolerance, the catalytic dead strain of Rev1 exhibits a lower 4-NQO-induced mutation frequency than wild type. Furthermore, Pol ζ, but not Pol η, also contributes to 4-NQO resistance. These results show that Rev1's catalytic activity is important in vivo when the cell has to cope with specific DNA lesions, such as N(2)-dG.
Collapse
|